Background
There is a need for affordable ways to help people with anxiety disorders. DIALOG+ is a proven method designed to improve meetings between patients and healthcare providers in mental health care. While it has shown benefits in various studies, it had not been tested specifically for anxiety disorders until now.
Methods
We conducted a pilot study in an outpatient service in Buenos Aires, Argentina. DIALOG+ was used five times over six months. Due to the pandemic, all sessions were held online, which was not the original plan. We measured outcomes like quality of life, general symptoms, and social situations before and after the intervention. We also gathered patient feedback through interviews.
Results
Forty patients completed the study. We found significant improvements in:
- Quality of life: Increased from 4.1 to 5.0 (p<0.001)
- General symptoms: Decreased from 33.0 to 25.9 (p<0.001)
- Social situation: Increased from 5.2 to 5.6 (p=0.008)
Patients reported mostly positive experiences, even though there were some technical issues with the online format.
Conclusions
The results suggest that DIALOG+ is a practical and beneficial option for treating anxiety disorders in routine care, even when delivered remotely. Future research should explore how to implement this method effectively on a larger scale.
Opportunities Based on Trial Data
We can define measurable outcomes and set clear goals for clinics and patients using DIALOG+. This includes:
- Improving patient quality of life
- Reducing general symptoms of anxiety
- Enhancing social situations for patients
Selecting AI Tools
Choose AI solutions that meet specific clinical needs to support the implementation of DIALOG+.
Implementation Steps
Start with a pilot project, track results using AI tools, and assess the real-world impact of DIALOG+ on patients with anxiety disorders.
Contact Us
For AI solutions in medical management, reach out to us:
- Telegram: https://t.me/itinai
- X: https://x.com/vlruso
- LinkedIn: https://www.linkedin.com/company/itinai/
